Total Payments
$19,967
2021 Payments
$1,944
Companies
32
Transactions
393
Medicare Patients
318
Medicare Billing
$44,912
Payment Breakdown by Category
Food & Beverage$12,805 (64.1%)
Other$4,970 (24.9%)
Travel$1,111 (5.6%)
Consulting$724.00 (3.6%)
Education$356.46 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,805 | 361 | 64.1% |
| Honoraria | $4,850 | 2 | 24.3% |
| Travel and Lodging | $1,111 | 5 | 5.6% |
| Consulting Fee | $724.00 | 1 | 3.6% |
| Education | $356.46 | 22 | 1.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $120.00 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $6,436 | 14 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $1,975 | 53 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $1,561 | 33 | $0 (2021) |
| Novo Nordisk Inc | $1,520 | 51 | $0 (2020) |
| Amgen Inc. | $1,051 | 30 | $0 (2020) |
| Dr.Reddy's Laboratories,Inc. | $724.00 | 1 | $0 (2021) |
| Dexcom, Inc. | $718.21 | 22 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $575.80 | 27 | $0 (2020) |
| Lilly USA, LLC | $575.72 | 25 | $0 (2020) |
| AbbVie Inc. | $535.07 | 18 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $1,944 | 4 | Horizon Therapeutics plc ($1,100) |
| 2020 | $1,808 | 54 | Companion Medical, Inc. ($410.36) |
| 2019 | $8,558 | 107 | Horizon Therapeutics plc ($5,244) |
| 2018 | $3,211 | 85 | AstraZeneca Pharmaceuticals LP ($573.30) |
| 2017 | $4,446 | 143 | AstraZeneca Pharmaceuticals LP ($901.61) |
All Payment Transactions
393 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2021 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $70.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/13/2021 | Dr.Reddy's Laboratories,Inc. | — | Consulting Fee | Cash or cash equivalent | $724.00 | General |
| 06/02/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $50.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/05/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $1,100.00 | General |
| Category: TEPEZZA | ||||||
| 10/29/2020 | Medtronic MiniMed, Inc. | InPen (Device) | Food and Beverage | In-kind items and services | $74.80 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 09/10/2020 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: Endocrinology | ||||||
| 09/09/2020 | Companion Medical, Inc. | InPen (Device) | Food and Beverage | In-kind items and services | $63.96 | General |
| Category: Diabetes | ||||||
| 09/08/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Bone Health | ||||||
| 09/01/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/28/2020 | Xeris Pharmaceuticals, Inc. | GVOKE PFS (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: DIABETES | ||||||
| 08/25/2020 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $21.25 | General |
| Category: Oncology | ||||||
| 08/21/2020 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | Cash or cash equivalent | $19.24 | General |
| Category: Endocrinology | ||||||
| 08/20/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/11/2020 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: IMMUNOLOGY | ||||||
| 07/10/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/09/2020 | Companion Medical, Inc. | InPen (Device) | Food and Beverage | In-kind items and services | $95.81 | General |
| Category: Diabetes | ||||||
| 07/07/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Bone Health | ||||||
| 06/30/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/26/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Endocrinology | ||||||
| 06/25/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/23/2020 | Companion Medical, Inc. | InPen (Device) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Diabetes | ||||||
| 06/18/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Diabetes | ||||||
| 06/16/2020 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: IMMUNOLOGY | ||||||
| 06/05/2020 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: DIABETES MEDICINE | ||||||
| 05/28/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 4 | 318 | 468 | $88,587 | $44,912 |
Total Patients
318
Total Services
468
Medicare Billing
$44,912
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 217 | 352 | $70,320 | $36,344 | 51.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 64 | 68 | $11,617 | $5,569 | 47.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 13 | 13 | $3,325 | $2,081 | 62.6% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 24 | 35 | $3,325 | $918.43 | 27.6% |
About Thomas Knecht, MD, PHD
Thomas Knecht, MD, PHD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Petaluma, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2009. The National Provider Identifier (NPI) number assigned to this provider is 1235371857.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Thomas Knecht, MD, PHD has received a total of $19,967 in payments from pharmaceutical and medical device companies, with $1,944 received in 2021. These payments were reported across 393 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($12,805).
As a Medicare-enrolled provider, Knecht has provided services to 318 Medicare beneficiaries, totaling 468 services with total Medicare billing of $44,912. Data is available for 1 year (2020–2020), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Petaluma, CA
- Active Since 03/27/2009
- Last Updated 04/24/2015
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1235371857
Products in Payments
- FARXIGA (Drug) $1,458
- TEPEZZA (Drug) $1,158
- TOUJEO (Drug) $656.50
- InPen (Device) $594.89
- Repatha (Biological) $534.83
- Dexcom G5 Mobile CGM System (Device) $501.85
- JARDIANCE (Drug) $466.72
- BYDUREON (Drug) $454.22
- PRALUENT ALIROCUMAB INJECTION (Biological) $425.50
- Ozempic (Drug) $373.28
- AFREZZA (Drug) $366.36
- Vascepa (Drug) $339.68
- INVOKANA (Drug) $320.96
- Victoza (Drug) $294.36
- Prolia (Biological) $272.99
- DIABETES - DISEASE (Drug) $261.85
- JANUVIA (Drug) $252.41
- EVENITY (Biological) $226.97
- Androgel (Drug) $220.44
- STEGLATRO (Drug) $218.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.